首页> 外国专利> 5-HT4 RECEPTOR AGONISTS FOR THE TREATMENT OF DEMENTIA.

5-HT4 RECEPTOR AGONISTS FOR THE TREATMENT OF DEMENTIA.

机译:5-HT4受体激动剂,用于痴呆症的治疗。

摘要

This invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof with 5-HT4 agonistic activities, which is useful in the treatment of dementia. This invention also relates to a pharmaceutical composition for the treatment of dementia which comprises a therapeutically effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof. Further this invention relates to a method for the treatment of dementia in an animal subject including a mammalian subject, which comprises administering to the animal subject including a mammalian subject a compound of the formula (I) or a pharmaceutically acceptable salt thereof.
机译:本发明涉及具有5-HT 4激动活性的式(I)化合物或其药学上可接受的盐,其可用于治疗痴呆。本发明还涉及用于治疗痴呆的药物组合物,其包含治疗有效量的式(I)的化合物或其药学上可接受的盐。本发明还涉及在包括哺乳动物受试者的动物受试者中治疗痴呆的方法,其包括向包括哺乳动物受试者的动物受试者施用式(I)的化合物或其药学上可接受的盐。

著录项

  • 公开/公告号MX343165B

    专利类型

  • 公开/公告日2016-10-26

    原文格式PDF

  • 申请/专利权人 RAQUALIA PHARMA INC.;

    申请/专利号MX20120009211

  • 申请日2011-02-14

  • 分类号A61K31/454;A61P25/14;A61P43;C07D405/14;

  • 国家 MX

  • 入库时间 2022-08-21 14:24:00

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号